J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company’s market cap increased $15 billion in response.

Johnson & Johnson's June regulatory filings revealed nearly $15 billion in cash reserves, signaling the company can easily pay the judge's fine.